Third module of patient partner and researcher training in development

Opportunity for patients and research teams to provide feedback on third imPORTND module ‘Skills for Patient-Oriented Research’

 

In February 2023, we launched our ‘imPORTND’ platform to offer two online training modules on how to conduct research that is informed by, and most meaningful to, individuals living with neuromuscular disorders. Since the launch we have seen over 100 users access the platform, and we are excited to share that a third training module is currently in development. ‘Skills for Patient-Oriented Research’ includes content on how to develop an effective patient engagement plan, how to share and listen to patient stories, how to work effectively in groups and how to evaluate the project engagement. 

Help test the third module

We are currently seeking patients and research team members to test this module and provide feedback on user experience and content relevance. If you or your research team would like to help test the third module, please contact network manager Erin Beattie at <>. 

 

The imPORTND training modules are available for free in both English and French.

Third imPORTND training module in development. 'Skills for patient-oriented research' will provide applied tools for patients and researchers to conduct patient-oriented research.

Read next...

SMA outcome measures training graphic

SMA Outcome Measures Training for Physiotherapists and Occupational Therapists

To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.

Congratulations to the 2024 early career award winners. Dr Mireille Khacho and Dr Jean-Philippe Leduc Gaudet.

Congratulations to the 2024 NMD4C Early Career Awards Recipients

We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.

Pediatric Rare Disease Clinical Trials and Treatment Network - RareKids-CAN

MICYRN Secures $20 Million Grant from CIHR for a Pediatric Rare Disease Clinical Trials and Treatment Network

The NMD4C are excited to share that MICYRN’s success in securing a $20 million grant from CIHR Institute of Genetics to support the development and execution of RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network.

CNDR logo4x3

CNDR Welcomes Dr. Hugh McMillan as New Pediatric Lead

CNDR warmly welcome Dr. Hugh McMillan as the new CNDR Pediatric Lead and are grateful for the wealth of knowledge, expertise, and leadership he will bring to the role.  

NMD4C Hires two new Coordinators - Zainab and Victoria

NMD4C Welcomes Two New Staff Members

The NMD4C recently welcomed two new members to the network coordination team! Marine Christin, PhD joins us as the new Pre-Clinical Science Coordinator, and Maria Masnata, PhD joins as the Clinical Trials & Community Practice Manager. 

Journal of neuromuscular diseases

Journal of Neuromuscular Diseases Celebrates 10-Year Anniversary with Commemorative Editorial

The January 2024 edition of the Journal of Neuromuscular Diseases (JND) marked the journal’s 10-year anniversary!